Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 USD | +4.17% | +4.14% | +113.75% |
15/03 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/01 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Sales 2022 | 4.01 334.5 | Sales 2023 | - | Capitalization | 122M 10.16B |
---|---|---|---|---|---|
Net income 2022 | -32M -2.67B | Net income 2023 | -24M -2B | EV / Sales 2022 | -2,75,90,059 x |
Net cash position 2022 | 217M 18.14B | Net cash position 2023 | 200M 16.69B | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.38% |
1 day | +4.47% | ||
1 week | +4.14% | ||
Current month | +11.47% | ||
1 month | +0.94% | ||
3 months | +57.46% | ||
6 months | +96.10% | ||
Current year | +113.75% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 22/05/22 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 01/15/01 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 31/21/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 20/18/20 |
William McKenzie
BRD | Director/Board Member | 76 | 01/09/01 |
John Simard
CEO | Chief Executive Officer | 62 | 22/05/22 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 8.57 | +5.02% | 14 260 |
01/24/01 | 8.16 | +6.39% | 154,952 |
30/24/30 | 7.67 | -1.16% | 92,619 |
29/24/29 | 7.76 | -1.40% | 95,706 |
26/24/26 | 7.87 | -4.14% | 59,355 |
Delayed Quote Nasdaq, May 03, 2024 at 12:15 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+113.75% | 248M | |
-1.47% | 104B | |
+6.73% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.84% | 16.36B | |
+7.78% | 14.39B | |
+36.76% | 12.37B |
- Stock Market
- Equities
- XBIT Stock